· Executive Brief
World Brain Tumor Day 2026
An executive-guidance framework for coordinated messaging, visible ownership, and a measured improvement cycle.
Leadership signal
World Brain Tumor Day can serve as an executive operating checkpoint.
Coordination matters when multiple teams participate. An executive review can prevent conflicting instructions, unowned inquiries, duplicated outreach, and disconnected follow-up by establishing a shared brief, named owners, and a visible exception process.
Start by distinguishing what is known from what the organization still needs to learn. A campaign plan, communication volume, or meeting count does not establish that a route is usable. Leaders need direct listening, clear ownership, locally defined measures, and a method for keeping exceptions visible.
Executive opening
Brain tumor care is a long journey that needs a coordinated operating system
A brain tumor diagnosis changes thinking, movement, speech and personality, often within weeks. Patients and families then move through surgery, radiation, chemotherapy, rehabilitation, recurrence and, for many, end-of-life care. Each phase involves different specialists, sites and schedules. World Brain Tumor Day is a reasonable moment for executives to ask how well those phases connect for the people living through them.
The research shows that supportive services exist but reach patients unevenly. In a survey of 75 family caregivers of people living with glioblastoma, only 28% reported palliative care involvement.[4] Fewer than 10% correctly identified all the functions of palliative care defined by the World Health Organization.[4] Yet at one center, specialized palliative care was associated with longer overall survival after adjustment for known prognostic factors (hazard ratio 0.707).[3]
Rehabilitation shows a similar gap between need and use. Among 10,275 adults in a national claims sample who had brain tumor surgery, 9.3% were discharged to inpatient rehabilitation facilities and 9.5% to skilled nursing facilities.[15] A scoping review of rehabilitation guidance found under-referral and inconsistent referral pathways across documents.[10] Where people live and how they are insured also shape what care they receive and how long they survive.[9][13] Each of these gaps can be measured, assigned and improved by teams the organization already employs.
This brief adds the evidence behind the live guidance. It covers burden and patient-reported outcomes, then the continuum from surgery to survivorship and access to treatment and trials. It closes with equity, the nurses, therapists and palliative teams who carry the work, and communication with patients and caregivers. The executive question is whether one accountable team holds the whole pathway together. Without that team, families become the coordinators by default, often while coping with the same cognitive and emotional changes the illness brings.
Current evidence
What the research shows about symptom burden, palliative care and long-term outcomes
Brain tumors carry a heavy and lasting symptom burden. A prospective study followed 180 adults with malignant brain tumors after proton therapy, with 80 completing the 60-month follow-up.[12] Over five years, fatigue increased and stayed above baseline, while cognitive and physical functioning showed sustained declines.[12] Emotional, role and social functioning improved, and drowsiness, leg weakness and bladder control problems emerged as long-term challenges.[12]
Those findings matter for survivorship planning. The authors concluded that structured, long-term rehabilitation and follow-up strategies are needed.[12] For health systems, that means patient-reported outcome measures should continue well beyond active treatment, and someone must be assigned to respond when scores worsen. A score that is collected but never reviewed adds burden for patients without improving their care.
Early palliative care has now been tested in a randomized trial. The EPCOG trial at six German university medical centers randomized 109 glioblastoma patients to early integrated palliative care and 108 to standard care.[1] Quality of life at six months favored the intervention but was not statistically significant (mean difference 4.1).[1] In an analysis adjusted for time of death, quality of life was better in the intervention group, and patients benefited on palliative care problems and mood.[1]
The trial also found a significant survival difference favoring the control group, which the authors addressed in their adjusted analysis.[1] Caregivers did not appear to benefit from the intervention, which suggests that caregiver support needs its own design.[1] The authors concluded that early palliative care improves how patients live, though not their length of life.[1] That distinction is useful for leaders explaining the purpose of palliative integration to clinicians and families. It also shows why trials of supportive care must plan for the rapid decline many patients experience. Measuring quality of life in a population with high early mortality requires careful design.
Real-world data from routine care add useful context. In a retrospective study of 274 glioblastoma patients at one center, 91.6% received neuro-oncology-focused primary palliative care and 76.6% received specialized palliative care.[3] Patients with specialized palliative care were less likely to receive tumor-specific therapy in the 30 days before death (odds ratio 0.302).[3] Median overall survival was 16.9 months with specialized palliative care, compared with 12.9 months without, though that crude difference was not significant.[3]
Figure 1
Supportive care reaches some brain tumor patients well and others rarely
Percent of each study population, as reported. Values are copied from the cited studies [2], [3], [4], [7], [15]; none is estimated.
Data note. These values come from different countries, settings and measures, so this is an indirect comparison; the bars show how unevenly supportive services reach patients, not how one program compares with another.
Limitation. Several values come from single centers or self-selected survey samples, and the rehabilitation figure reflects discharge setting only.
Figure data (5 rows)
| Measure | Value | Population, setting and year as reported | Source |
|---|---|---|---|
| Survivors returning to work after tele-based vocational cognitive rehabilitation | 82% | 28 survivors of primary brain tumors, one academic medical center | [7] |
| Glioblastoma patients receiving specialized palliative care | 76.6% | 210 of 274 patients, single center | [3] |
| Screened glioblastoma patients enrolled in an early palliative care trial | 41.5% | 556 patients screened, multicenter trial in Germany | [2] |
| Caregivers reporting palliative care involvement | 28% | 75 family caregivers of people with glioblastoma, online survey, 2024 | [4] |
| Adults discharged to inpatient rehabilitation after brain tumor surgery | 9.3% | 10,275 adults in national claims data, diagnosed 2015 to 2019 | [15] |
Continuum of care
Where the brain tumor pathway breaks after surgery and treatment
The brain tumor continuum runs from imaging and diagnosis through surgery, adjuvant treatment, rehabilitation, surveillance and, often, recurrence and end-of-life care. Responsibility moves between neurosurgery, radiation oncology, medical oncology, rehabilitation, primary care and palliative care. The research highlights the transition out of the acute hospital and the long survivorship phase as weak joints. At both points, the team that knows the patient best is often handing care to a team that has never met her.
Discharge after surgery is the first major handoff. In the national claims study, over two thirds of patients were discharged directly home, with or without home health care.[15] About 13.5% went to other settings, and the average length of stay during the episode of care was 8.6 days.[15] Patients with benign tumors, older age and more comorbidities were more likely to go to inpatient rehabilitation or skilled nursing than home.[15]
Rehabilitation guidance is broad but not yet operational. A scoping review of 17 documents, including five guidelines or consensus statements, found that multidisciplinary rehabilitation was consistently recommended.[10] Early and longitudinal approaches were advocated, but referral pathways and implementation practices remained inconsistent.[10] Major gaps included limited tumor-specific protocols, under-referral and uncertainty about the best rehabilitation setting.[10]
Return to work is a survivorship milestone that health systems rarely track. In a retrospective review at an academic medical center, 35 of 77 survivors of primary brain tumors were working at referral and 42 were unemployed.[7] Unemployment was associated with worse verbal learning and memory.[7] Among 28 people who received tele-based vocational cognitive rehabilitation, 82% returned to work.[7] The authors noted that work status improved in the context of this rehabilitation and called for further study.[7]
These studies point to a pathway that often ends at discharge from active treatment. In the vocational program, interventions addressed cognitive, emotional, fatigue and practical workplace challenges together, delivered during standard clinical care.[7] Patients then manage cognitive change, fatigue and work disruption with limited structured support. Executives should ask whether survivorship visits include cognitive screening and rehabilitation referral by default, and who owns the response. Tumor boards that discuss only surgical and oncologic options can add a standing rehabilitation and supportive care review for each new patient.
Figure 3
Why the pathway breaks
People
- Caregivers carry unmet physical and emotional support needs
- Cognitive change limits patients’ ability to self-navigate
- Few clinicians trained in cognitive and vocational rehabilitation
Process
- No default palliative care discussion after diagnosis
- Rehabilitation referral pathways inconsistent
- Survivorship follow-up ends with active treatment
Technology
- Patient-reported outcomes not tracked long term
- Telehealth formats vary in acceptability
- Trial and treatment schedules not coordinated across sites
Environment
- Long commuting distances for repeated treatment
- Rural residence with fewer specialist services
- Structural issues delaying neurosurgical visits
Policy
- Insurance type shapes rehabilitation setting
- Limited financial support for caregivers
- Few tumor-specific rehabilitation protocols
Measurement
- Palliative care involvement not measured
- Return to work not recorded
- Outcomes not stratified by rurality, insurance and income
Unranked qualitative cause-and-effect diagram for the outcome in the box: People with brain tumors and their caregivers do not receive timely palliative, rehabilitation and survivorship support Causes are assembled from the cited literature [2], [4], [7], [8], [9], [10], [12], [13], [14], [15]; categories are not weighted and their order carries no meaning.
Data note. Qualitative; no frequencies are implied.
Limitation. Causes drawn from published studies may not all apply locally; validate them with frontline teams.
Figure data (6 rows)
| Category | Causes drawn from the cited literature |
|---|---|
| People | Caregivers carry unmet physical and emotional support needs; Cognitive change limits patients’ ability to self-navigate; Few clinicians trained in cognitive and vocational rehabilitation |
| Process | No default palliative care discussion after diagnosis; Rehabilitation referral pathways inconsistent; Survivorship follow-up ends with active treatment |
| Technology | Patient-reported outcomes not tracked long term; Telehealth formats vary in acceptability; Trial and treatment schedules not coordinated across sites |
| Environment | Long commuting distances for repeated treatment; Rural residence with fewer specialist services; Structural issues delaying neurosurgical visits |
| Policy | Insurance type shapes rehabilitation setting; Limited financial support for caregivers; Few tumor-specific rehabilitation protocols |
| Measurement | Palliative care involvement not measured; Return to work not recorded; Outcomes not stratified by rurality, insurance and income |
Access
Making specialized neuro-oncology care reachable across distance and phase
Distance shapes access to complex brain tumor care. A Japanese study measured commuting distances for 564 glioblastoma patients treated at 11 institutions between 2010 and 2023.[14] Among the 452 patients who received second-line treatment for recurrence, median overall survival was 18.7 months for those living nearby and 16.8 months for those farther away.[14] Commuting distance was an independent prognostic factor in multivariable analysis.[14]
The authors called for an environment that enables smooth and continuous delivery of multimodal treatment, particularly in rural areas.[14] The survival difference by distance appeared among patients needing second-line treatment, such as bevacizumab, for which rural patients often travel long distances.[14] For U.S. systems, that points to regional partnerships, shared protocols with community oncology sites and virtual visits for parts of care that do not require a specialist center. Transportation support and lodging can also make repeated treatment visits feasible. Navigators who know each patient’s distance from the treatment center can plan visits in clusters and flag patients at risk of missed care.
Rural residence carries a measurable gap in the United States. Among 10,632 patients with IDH-wildtype glioblastoma, 1,193 lived in rural counties.[13] Rural patients were less likely to receive radiotherapy (71.8% versus 76.7%) or chemotherapy (69.2% versus 73.4%), although resection rates were similar.[13] One-year overall survival was 37% in rural areas compared with 45% in urban areas.[13]
Virtual rehabilitation can extend access to scarce cognitive services. An interim pilot study of tele-cognitive rehabilitation for adults with lower-grade glioma enrolled 33 of 39 eligible participants, an 85% enrollment.[8] Goal Management Training showed adequate feasibility and satisfaction, while app-based and texting formats had challenges with acceptability or feasibility.[8] The authors recommended further investigation of individual telehealth Goal Management Training.[8] Participants were a median of 64.8 months from diagnosis, which shows that cognitive needs persist years after treatment.[8]
Access to clinical trials depends on how trials are run. In a sub-analysis of the EPCOG trial, 41.5% of 556 screened patients were enrolled.[2] The main reasons for non-participation were lack of interest (25.7%) and low functional status (11.5%).[2] Structural issues were behind more than half of deviations in neurosurgical visits, while specialized palliative care visits were least often skipped, at 4.5%.[2] Neurosurgical visits were skipped 43.3% of the time.[2] Scheduling, staffing and clinic structure therefore affect trial access as much as patient willingness does.
Executive guidance · System route
Build one visible operating route for World Brain Tumor Day.
Use this route as a discussion framework. Replace each stage with the organization’s approved process, qualified roles, current service capacity, and applicable requirements. Do not infer a clinical protocol from the observance title.
The route at a glance
- Define the purpose
- Align the entry point
- Navigate across services
- Manage response
- Review the campaign
Reliability rule: Every stage needs a named owner, an observable status, an approved escalation path, and a defined signal that shows whether responsibility moved or remained unresolved.
Define the purpose
Name the audience, intended action, approved message, and limits of what the campaign can responsibly promise.
Align the entry point
Connect every communication channel to current information and a clearly identified receiving role or team.
Navigate across services
Make the receiving service, required information, current status, and next accountable owner visible whenever the route crosses an organizational boundary.
Manage response
Keep questions, referrals, exceptions, and unresolved work visible until an accountable receiver accepts them.
Review the campaign
Compare intended action with local process signals and partner feedback, then document the improvement to carry forward.
Figure 2
The system route as one flow
The five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.
Data note. Shows sequence and handoffs only; it carries no counts or rates.
Limitation. Local processes may add, merge or reorder stages under organizational policy.
Figure data (5 rows)
| Stage | What the stage requires |
|---|---|
| Define the purpose | Name the audience, intended action, approved message, and limits of what the campaign can responsibly promise. |
| Align the entry point | Connect every communication channel to current information and a clearly identified receiving role or team. |
| Navigate across services | Make the receiving service, required information, current status, and next accountable owner visible whenever the route crosses an organizational boundary. |
| Manage response | Keep questions, referrals, exceptions, and unresolved work visible until an accountable receiver accepts them. |
| Review the campaign | Compare intended action with local process signals and partner feedback, then document the improvement to carry forward. |
Equity and trust
Equity gaps in brain tumor care follow place, insurance and income
Insurance type shapes both rehabilitation and later use of care. In a commercial and Medicaid claims analysis, 12 504 adults with commercial insurance and 1875 with Medicaid had surgery for a malignant primary brain tumor.[9] Both groups had similar overall rehabilitation use at 12 months, but patients with Medicaid used more home health, skilled nursing and inpatient rehabilitation.[9] Patients with commercial insurance used more outpatient rehabilitation.[9]
Downstream utilization diverged sharply. At 12 months after discharge, emergency room visits occurred among 65.60% of patients with Medicaid, compared with 49.60% with commercial insurance.[9] Hospital admissions were 40.60% versus 36.30%.[9] The authors called for research on actionable changes to reduce these possible disparities.[9] For health systems, these figures suggest that outpatient rehabilitation and care coordination may be less available to patients with Medicaid. Index surgery hospitalization was also longer for patients with Medicaid.[9]
Demographic and economic factors also affect discharge and length of stay. In the national claims study, wealthier patients were less likely to be discharged to skilled nursing than home.[15] Black and Hispanic patients, along with the oldest patients and those with more comorbidities, had longer acute hospital stays.[15] The authors called for study of barriers to rehabilitation access in this population.[15]
Rural disparities were concentrated among younger adults. In the registry glioblastoma cohort, rural residence was associated with shorter survival overall (time ratio 0.89).[13] The association was more evident in adults aged 18 to 64 years (time ratio 0.86) and smaller and not significant in those 65 and older.[13] Working-age patients in rural areas may face competing demands of employment, travel and family care. Not receiving radiotherapy (time ratio 0.51) or chemotherapy (time ratio 0.42) was strongly associated with shorter survival in the same cohort.[13] Closing gaps in treatment receipt is therefore one of the most direct equity levers available.
Caregiver resources are an equity issue as well. In a study of 216 patient-caregiver dyads in China, caregiver monthly income was a significant predictor of caregiver psychosocial adjustment, with higher income associated with better adjustment.[6] The authors recommended multilevel interventions that pair dyadic psychological support with targeted economic assistance.[6] Social work and financial counseling therefore belong in the core neuro-oncology team. Their involvement should be triggered by diagnosis, not by a crisis months later.
Human infrastructure
The nurses, therapists and palliative teams who carry neuro-oncology care
Nurses can lead structured rehabilitation for common complications. A randomized controlled trial assigned 120 brain tumor patients with dysphagia to a nurse-led multimodal intervention or conventional care.[11] The program combined personalized swallowing training, nutritional support, psychological care and family participation, adjusted by nurses, rehabilitation therapists and dietitians.[11] Swallowing function and quality of life improved significantly more in the intervention group.[11]
That trial shows how much depends on team design. Swallowing problems affect nutrition, safety and the ability to go home, yet they are often managed piecemeal. A nurse-led model with clear roles for therapists and dietitians gives the patient one coordinated plan. Executives can ask whether similar nurse-led protocols exist for other common problems, such as seizures, fatigue and cognitive change. Nurse navigators who follow each patient across phases can carry those protocols from the hospital into outpatient care.
Cognitive rehabilitation requires specialized clinicians. In the vocational rehabilitation program, the most common interventions among responders included executive and organizational skills training, mental health counseling, job simulations and accommodations, and fatigue education.[7] Delivering that mix requires neuropsychologists, occupational therapists and counselors working from a shared plan. Participants received a mean of 10 sessions.[7] The authors described the intervention as multimodal and individualized, addressing cognitive, emotional, fatigue and practical workplace challenges.[7]
Palliative care teams also make research and care more reliable. In the EPCOG sub-analysis, only 11.0% of specialized palliative care visits were delayed, compared with 22.3% of outcome assessment visits and 56.4% of neurosurgical visits.[2] The authors linked this to close guidance, patient- and caregiver-oriented communication, home-based assessment visits and a study nurse at each site.[2] Those same features can make routine care more dependable.
The workforce extends to family caregivers, who provide much of the outpatient care. Caregivers in the glioblastoma survey reported unmet needs for physical and emotional support, symptom management and treatment side effect management.[4] Patients’ illness perceptions were associated with caregivers’ psychosocial adjustment, but not the reverse.[6] Supporting caregivers is part of supporting patients, and the clinical team should plan for both. Caregiver check-ins at key transitions, such as discharge and recurrence, are a simple place to start. Staff time for those check-ins should be scheduled rather than left to chance.
Executive guidance · Operating dashboard
Use a small dashboard to expose friction and ownership.
Do not publish a number until the organization defines its numerator, denominator where relevant, owner, source system, exclusions, review cadence, and limits. The candidates below are management prompts, not benchmarks or reported results.
Four operating signals
Each signal pairs an executive question with one candidate local measure, set out below.
Executive guidance · Signal
Message alignment
Do channels and partners communicate one current and appropriately bounded route?
- Candidate local measure
- Content review status, conflicting instructions, corrections, and unresolved questions.
Executive guidance · Signal
Response ownership
Does every campaign-generated request reach an accountable receiver?
- Candidate local measure
- Routing, acknowledgment, repeat contact, unresolved work, and escalation signals.
Executive guidance · Signal
Navigation continuity
Where does ownership become unclear as people move among information, evaluation, services, and follow-through?
- Candidate local measure
- Locally defined unaccepted handoffs, repeated contacts, missing information, unresolved routes, and navigation feedback.
Executive guidance · Signal
Action closure
Did leaders complete and verify the improvement selected for the campaign window?
- Candidate local measure
- Assigned action, status, evidence of completion, and post-action review.
Figure 4
The operating system behind the dashboard
The four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.
Data note. Structural diagram; no measured values.
Limitation. Owners are candidates to be confirmed locally.
Figure data (4 rows)
| Operating signal | Candidate owner |
|---|---|
| Message alignment | Executive sponsor and operational lead |
| Response ownership | Operational owner and participating teams |
| Navigation continuity | Sending and receiving owners |
| Action closure | Improvement owner and executive sponsor |
Executive guidance · Handoff workflow
Close the loop across teams, settings, and partners.
A handoff is reliable only when the sending party knows who is expected to receive the work, the receiving party acknowledges responsibility, and any unresolved exception remains visible. Local policy and qualified judgment control the actual process.
How responsibility moves
Lane A
From message to accepted ownership
- Confirm the approved message and intended audience.
- Publish the actual entry point and receiving role.
- Acknowledge receipt using the locally approved method.
- Escalate when ownership or response remains unclear.
Lane B
From accepted ownership to verified follow-through
- Record the next accountable owner and visible status.
- Name the receiving service and confirm acceptance without promising a clinical determination or outcome.
- Keep unresolved work visible across boundaries.
- Confirm closure or document the continuing exception.
Executive guidance · Executive scorecard
Give leaders one view of route reliability and improvement.
The scorecard keeps review focused on decisions. Leaders should set definitions locally, examine variation without overclaiming cause, and pair quantitative signals with the experience of people who use and operate the route.
Who reviews what
- Executive sponsor and operational lead
- Operational owner and participating teams
- Sending and receiving owners
- Improvement owner and executive sponsor
Candidate owners named in the scorecard, confirmed locally.
| Operating signal | Executive question | Candidate owner | Suggested review point |
|---|---|---|---|
| Message alignment | Do channels and partners communicate one current and appropriately bounded route? | Executive sponsor and operational lead | At campaign launch and close |
| Response ownership | Does every campaign-generated request reach an accountable receiver? | Operational owner and participating teams | At a locally defined cadence |
| Navigation continuity | Where does ownership become unclear as people move among information, evaluation, services, and follow-through? | Sending and receiving owners | At a locally defined cadence |
| Action closure | Did leaders complete and verify the improvement selected for the campaign window? | Improvement owner and executive sponsor | Until action is verified |
Figure 5
Control points for a reliable neuro-oncology pathway
| Control point | Risk if missing | Owner | Evidence of control |
|---|---|---|---|
| Palliative care discussion and referral offered early after diagnosis | Families never hear what palliative care offers | Neuro-oncology program director with palliative care lead | Share of patients with a documented palliative care discussion within the first months |
| Rehabilitation assessment before surgical discharge | Patients go home without needed therapy | Neurosurgery service line leader with rehabilitation medicine | Share of postoperative patients with a rehabilitation assessment and referral |
| Cognitive and work status screening in survivorship visits | Cognitive decline and unemployment go unaddressed | Survivorship program lead | Screening completion and referrals to cognitive or vocational rehabilitation |
| Distance and travel support for repeated treatment | Remote patients miss or delay second-line care | Patient navigation manager | Travel support use and treatment completion by distance |
| Caregiver needs assessment with social work and financial counseling | Caregiver distress and financial strain go unseen | Director of oncology social work | Caregiver assessments completed and resources provided |
| Equity review of treatment and utilization data | Rural, Medicaid and low-income patients receive less care | Chief quality officer | Treatment receipt and emergency visits stratified by rurality and insurance |
Control points derived from the cited evidence [3], [4], [7], [9], [13], [14], [15] and this brief’s executive guidance.
Data note. Each row is a control to verify, not a measured result.
Limitation. Owners and evidence of control must follow local policy and applicable requirements.
Public communication
Communicating about palliative care, prognosis and recovery
Communication about palliative care is still a major gap. In the caregiver survey, a significant association was found between caregiver-reported discussions about palliative care and use of palliative care services.[4] The authors highlighted opportunities to improve communication about palliative care and strengthen supportive services.[4] Families cannot request a service they do not understand or have never heard discussed. Making the palliative care conversation a routine step, rather than a judgment call, removes much of that variation.
Misconceptions are common and correctable. With fewer than 10% of caregivers able to identify all functions of palliative care, many may still equate it with end-of-life care alone.[4] Clinicians can describe palliative care as symptom, mood and decision support that runs alongside tumor treatment. The EPCOG results support that framing, since patients benefited on palliative care problems and mood.[1]
Communication can also draw on patients’ strengths. In a cross-sectional study of 141 patients and caregivers recruited through online neuro-oncology support and advocacy groups, 70% of patients reported moderate-to-high post-traumatic growth.[5] Patients with high-grade tumors showed significantly higher growth than those with low-grade tumors.[5] Appreciation of life was the most frequently endorsed area in both patients and caregivers.[5] The authors suggested that psychosocial and palliative interventions could support growth through meaning-making and existential engagement.[5]
Honest communication about function and recovery helps families plan. In the five-year proton therapy study, visual and motor dysfunction and communication deficits improved, while fatigue and cognitive decline persisted.[12] Explaining that some symptoms may improve and others may emerge later prepares patients for survivorship rather than surprising them. It also signals that the care team will remain involved long after treatment ends. Written survivorship plans that list expected late effects and whom to call can make that promise concrete for families.
Clinical trial communication shapes participation. The EPCOG authors noted that personal contact by the palliative care team and outcome visits at patients’ homes supported high motivation among participants.[2] Health systems that want broader trial access can apply those lessons to recruitment and retention. World Brain Tumor Day messages can emphasize that patients and families will be guided, not left to navigate alone. Public materials should name the services available, from rehabilitation to palliative care, and explain how to request them.
Executive guidance · 90-day plan
Turn the observance into one sustained operating change.
The time boxes below are a management framework, not a clinical timeline. Adjust them to risk, scope, governance, resources, stakeholder participation, and applicable review requirements.
Ninety days, three moves
- Days 1–30See the current route
- Days 31–60Build the reliable path
- Days 61–90Make the change visible
Days 1–30 · Listen and map
See the current route
- Name an executive sponsor and an operational owner.
- Listen to people using the route and representative frontline teams.
- Map how World Brain Tumor Day communications connect to real entry points, owners, transitions, and escalation.
- Select one recurring barrier that the organization can responsibly address.
Days 31–60 · Design and test
Build the reliable path
- Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
- Validate the design with every sending and receiving team involved.
- Test one cross-service navigation handoff and correct the point where status or ownership becomes unclear.
- Test the route in more than one representative setting or operating period where practical.
Days 61–90 · Implement and verify
Make the change visible
- Launch the redesigned route with a small set of locally defined measures.
- Review unresolved work and recurring friction using a learning approach.
- Correct implementation barriers and record who owns each remaining dependency.
- Report what changed, what evidence was reviewed, and what still requires live oversight.
Figure 6
The 90-day plan on one timeline
The 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.
Data note. Time boxes are a management framework, not a clinical timeline.
Limitation. Durations are uniform 30-day windows; real tasks may span windows.
Figure data (12 rows)
| Window | Action |
|---|---|
| Days 1–30 · Listen and map | Name an executive sponsor and an operational owner. |
| Days 1–30 · Listen and map | Listen to people using the route and representative frontline teams. |
| Days 1–30 · Listen and map | Map how World Brain Tumor Day communications connect to real entry points, owners, transitions, and escalation. |
| Days 1–30 · Listen and map | Select one recurring barrier that the organization can responsibly address. |
| Days 31–60 · Design and test | Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal. |
| Days 31–60 · Design and test | Validate the design with every sending and receiving team involved. |
| Days 31–60 · Design and test | Test one cross-service navigation handoff and correct the point where status or ownership becomes unclear. |
| Days 31–60 · Design and test | Test the route in more than one representative setting or operating period where practical. |
| Days 61–90 · Implement and verify | Launch the redesigned route with a small set of locally defined measures. |
| Days 61–90 · Implement and verify | Review unresolved work and recurring friction using a learning approach. |
| Days 61–90 · Implement and verify | Correct implementation barriers and record who owns each remaining dependency. |
| Days 61–90 · Implement and verify | Report what changed, what evidence was reviewed, and what still requires live oversight. |
Executive guidance · Leadership close
Make World Brain Tumor Day a starting point, not an endpoint.
Recognition matters. It becomes durable when leaders also listen, clarify the route, support the people operating it, close an identified gap, and report the result without claiming more than the evidence supports.
Leadership commitment
Make ownership visible, test the route, and report what improved.
Executive action kit · Day observance
Turn World Brain Tumor Day into accountable action.
An executive-guidance framework for coordinated messaging, visible ownership, and a measured improvement cycle.
Leadership focus
Use this observance to examine navigation, longitudinal ownership, and specialty-care coordination. Select one verified barrier, assign an accountable owner, and carry the improvement beyond the campaign window.
Workforce lens
Ask whether staffing, role clarity, training, tools, workload, and escalation support the people operating the information, diagnostic navigation, support, and follow-through pathway.
Patient and community lens
Make the approved first step clear. Test whether a person can move from information to an acknowledged next action without navigating conflicting instructions.
Equity and access lens
Review whether language, transportation, cost, digital access, disability, geography, or trust changes a person’s ability to complete the locally approved route.
Five-minute briefing
Inspect the operating sequence
Listen with people using the pathway, caregivers, navigation teams, clinical services, and community partners. Find one a confusing entry point, unowned transition, or unresolved navigation need, then test the locally approved route from entry through acknowledged follow-through.
- Define the purpose
- Align the entry point
- Navigate across services
- Manage response
- Review the campaign
Leadership actions for this week
- Name an executive sponsor and frontline operating owner.
- Ask people using and operating the pathway where ownership becomes unclear.
- Test one representative route from first question to acknowledged next step.
- Select one barrier that can be corrected without overstating the evidence.
- Set a review date and define how completion will be verified.
Candidate measures
Define every numerator, denominator where relevant, owner, data source, exclusions, cadence, and limitation locally. These are management prompts, not external benchmarks.
- Content review status, conflicting instructions, corrections, and unresolved questions.
- Routing, acknowledgment, repeat contact, unresolved work, and escalation signals.
- Locally defined unaccepted handoffs, repeated contacts, missing information, unresolved routes, and navigation feedback.
Department readiness checklist
- The public and staff entry points match the actual approved process.
- A specific role accepts each request, referral, or escalation.
- Handoffs include acknowledgment and a visible unresolved state.
- Language, disability, digital, transportation, and trust barriers receive explicit review.
- Communications do not introduce unsupported themes, statistics, or clinical advice.
- A named leader will review what changed after the observance.
Intended audiences
- Executive and Operational Leaders
- Patient Experience and Access Leaders
Staff communication template
During World Brain Tumor Day, our organization will connect awareness with a practical review of the information, diagnostic navigation, support, and follow-through pathway. Use approved information, identify the correct entry point, confirm ownership when work moves, protect privacy, and escalate unresolved barriers through local channels.
Community communication template
World Brain Tumor Day is an opportunity to share trustworthy information and make the next step easier to find. Use our approved channels for information and support. If a request changes hands, our goal is to keep ownership and follow-through visible.
Measurement worksheet
- Signal
- What observable condition will show whether the route works?
- Definition
- What is included, excluded, and counted?
- Owner
- Who reviews the signal and acts on exceptions?
- Cadence
- When will leaders review it?
- Equity check
- Which differences require protected, locally appropriate review?
- Closure
- What evidence will confirm the improvement was completed?
- Editorial review
- Completed
- Source records
- 2 listed under Authoritative resources
- Review standard
- Sourced facts remain separated from original executive guidance
- Clinical boundary
- No new statistical or clinical claim was added by this action kit
Sources and content boundary
Authoritative resources
Use note: All operating models, measures, scorecard questions, and action steps are original executive guidance. This article supports leadership planning and education. It does not replace clinical judgment, emergency procedures, legal advice, professional standards, organizational policy, or applicable federal, state, and local requirements.
Peer-reviewed references
References
Fifteen peer-reviewed sources, newest first. Each was individually verified through authenticated academic research databases. Bracketed numbers in the text link here; the original executive guidance on this page carries no citations because it is guidance, not a sourced claim. Sources last checked in those databases on .
- 1.Golla H, Nettekoven C, Hellmich M, Appelmann I, Bausewein C, Becker G, et al. Early palliative care for patients with glioblastoma: A randomized phase III clinical trial (EPCOG). Neuro-Oncology. 2026;28(1):226-240. https://doi.org/10.1093/neuonc/noaf230
- 2.Joshi M, Nettekoven C, Kochs S, Appelmann I, Bausewein C, Becker G, et al. Conducting a randomized controlled clinical trial on palliative care in patients with glioblastoma – what are the challenges?. Supportive Care in Cancer. 2026;34(5). https://doi.org/10.1007/s00520-026-10564-7
- 3.Lind LM, Fischl A, Goettl E, Herr W, Kaiser U, Koelbl O, et al. Palliative care interventions and outcome in patients with glioblastoma – a retrospective, single-center study. BMC Palliative Care. 2026;25(1):29. https://doi.org/10.1186/s12904-026-01987-4
- 4.Robbins L, Vreeling A, Ennis S, James E, Wallace M, Lutz BJ, et al. Family Caregivers of People Living With Glioblastoma Report Low Palliative Care Utilization and Limited Discussions About Palliative Care With Members of the Healthcare Team: A Cross-Sectional Survey Study. American Journal of Hospice & Palliative Care. 2026:10499091261498179. https://doi.org/10.1177/10499091261498179
- 5.Loughan AR, Braun SE, Lanoye A, Willis K, Hernand M. Post-traumatic growth in patients and caregivers after a primary brain tumor diagnosis. Journal of Neuro-Oncology. 2026;176(3):208. https://doi.org/10.1007/s11060-026-05454-1
- 6.Huang T, Du M, Deng Y, Zhan M, Li M, Xu P. Illness Perception and Psychosocial Adjustment in Brain Tumor Patients and Their Family Caregivers: An Actor-Partner Interdependence Model Analysis. Cancer Medicine. 2026;15(6):e71972. https://doi.org/10.1002/cam4.71972
- 7.Weyer Jamora C, Brie MS, Bracci PM, Smith EM, Luks TL, Phan S, et al. Proof of concept using vocational tele-cognitive rehabilitation to improve work status in primary brain tumor. Neuro-Oncology Practice. 2026:1. https://doi.org/10.1093/nop/npag066
- 8.Weyer-Jamora C, Brie MS, Bracci PM, Smith EM, Luks TL, Phan S, et al. Tele-cognitive rehabilitation for adult lower-grade glioma: An interim prospective pilot feasibility study. Neuro-Oncology Practice. 2026;13(1):126-138. https://doi.org/10.1093/nop/npaf073
- 9.Geczi K, Giovanazzi S, Alvarez-Madrid E, Gartner KE, Kaelin D, Ugiliweneza B, et al. Insurance-associated variance in rehabilitation utilization after initial malignant primary brain tumor resection. Neuro-Oncology Practice. 2026:1. https://doi.org/10.1093/nop/npag059
- 10.Verrienti G, Antonaci CE, Megliola G, De Gennaro L. Rehabilitation in patients with primary brain tumors: a scoping review of current guideline recommendations. Neurological Sciences. 2026;47(8):1-13. https://doi.org/10.1007/s10072-026-09226-7
- 11.Lu Y, Wu H. Assessment of the role and effectiveness of nurse-led multimodal intervention in the rehabilitation of dysphagia in patients with brain tumors. Supportive Care in Cancer. 2026;34(10). https://doi.org/10.1007/s00520-026-11203-x
- 12.Langegård UE, Fessé P, Fransson P, Ohlsson-Nevo E, Kristensen I, Kunni K, et al. Five years On: Lasting impact of proton therapy on health-related quality of life in brain tumor survivors. European Journal of Oncology Nursing. 2026;83. https://doi.org/10.1016/j.ejon.2026.103215
- 13.Miao W, Yang L, Li J, Fu Y, Yang Y, Yan X, et al. Age-specific disparities in rural and urban survival among patients with IDH-wildtype glioblastoma: a population-based study. Cancer Causes & Control. 2026;37(7). https://doi.org/10.1007/s10552-026-02198-1
- 14.Momii Y, Hata N, Fudaba H, Yonezawa H, Shinojima N, Negoto T, et al. Rural medical disparities in multimodal glioblastoma treatment. Scientific Reports. 2026. https://doi.org/10.1038/s41598-026-48867-8
- 15.McLarney M, Fergestrom N, Zheng J, Pezzin LE. Rehabilitation after brain tumor resection: A national study of postacute care service use through insurance claims data. PM&R. 2024;16(5):441-448. https://doi.org/10.1002/pmrj.13117
Claim-to-source matrix
What each source supports
Every sourced claim in the new sections maps to the references that support it, the section where it is used, and the limitation a reader should keep in mind. Original executive guidance carries no sources because it is guidance, not a finding.
| Claim group | Sources | Years | Used in | Limitation |
|---|---|---|---|---|
| Long-term health-related quality of life after proton therapy | [12] | 2026 | Current evidence | Single-arm longitudinal cohort with substantial loss to follow-up by 60 months. |
| Early integrated palliative care in glioblastoma | [1] [3] | 2026 | Current evidence | Randomized trial with a primary endpoint not met and a survival imbalance; single-center retrospective cohort. |
| Discharge settings and rehabilitation after brain tumor surgery | [15] [10] | 2026, 2024 | Continuum of care | Claims data from 2015 to 2019; scoping review of heterogeneous guidance. |
| Vocational and tele-cognitive rehabilitation | [7] [8] | 2026 | Continuum of care | Retrospective review and interim pilot data from one academic center. |
| Distance, rurality and treatment access | [14] [13] | 2026 | Access | Japanese multicenter cohort and U.S. registry data; observational associations. |
| Clinical trial participation and protocol deviations | [2] | 2026 | Access | Sub-analysis of a single German multicenter trial. |
| Insurance and rehabilitation and health care use | [9] | 2026 | Equity and trust | Commercial and Medicaid claims for adults aged 18 to 65; no clinical severity data. |
| Caregiver adjustment, income and unmet needs | [6] [4] | 2026 | Human infrastructure | Convenience samples from two Chinese hospitals and online caregiver groups. |
| Nurse-led dysphagia rehabilitation | [11] | 2026 | Human infrastructure | Single-hospital randomized trial over five months of enrollment. |
| Post-traumatic growth in patients and caregivers | [5] | 2026 | Public communication | Cross-sectional survey recruited through online support and advocacy groups. |
About the author
Greg Wahlstrom
MBAHCM
President and Chief Executive Officer, The Healthcare Executive
View Greg’s profile©2014 – 2026 The Healthcare Executive. All rights reserved.